Skip to main content

Market Overview

Milestone Scientific Reports Epidural, Intra-Articular Unit Will Present Initial Results of Trials for Instrument

Share:

Milestone Scientific Inc.'s (NYSE: MLSS) Epidural & Intra-Articular (IA) Subsidiary today announced that it will host an event on November 20th in Miami for a group of leading anesthesiologists and key opinion leaders in the field where it plans to present the interim results from its COMPASS clinical study for the epidural instrument. Milestone Scientific's Epidural & IA Subsidiary will also issue a press release following the event which will include data reviewed with the anesthesiology and pain management experts. The presentation will share how the CompuFlo® Epidural platform technology impacted the safety of epidural procedures and operational efficiencies, and address the potential for malpractice risk reduction.

Leonard Osser, Chief Executive Officer of Milestone Scientific, commented, "We look forward to unveiling the initial results of the clinical trials to a group of leading industry experts and the public at large. We believe the epidural instrument has the potential to transform an industry that has been plagued with safety concerns with one of the highest rates of malpractice in medicine. We believe these instruments represents the future of drug delivery."

 

Related Articles (MLSS)

View Comments and Join the Discussion!

Posted-In: News Press Releases

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com